These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34161136)

  • 1. Increasing Utilization of MRI Before Prostate Biopsy in Black and Non-Black Men: An Analysis of the SEER-Medicare Cohort.
    Gaffney CD; Cai P; Li D; Margolis D; Sedrakyan A; Hu JC; Shoag J
    AJR Am J Roentgenol; 2021 Aug; 217(2):389-394. PubMed ID: 34161136
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test.
    Abashidze N; Stecher C; Rosenkrantz AB; Duszak R; Hughes DR
    JAMA Netw Open; 2021 Nov; 4(11):e2132388. PubMed ID: 34748010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
    Leapman MS; Dinan M; Pasha S; Long J; Washington SL; Ma X; Gross CP
    JAMA Oncol; 2022 May; 8(5):687-696. PubMed ID: 35238879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States.
    Liu W; Patil D; Howard DH; Moore RH; Wang H; Sanda MG; Filson CP
    Urology; 2018 Jul; 117():57-63. PubMed ID: 29679601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Trends in Magnetic Resonance Imaging at the Time of Prostate Biopsy: Results from a Large Private Insurance Database.
    Kim SP; Karnes RJ; Mwangi R; Van Houten H; Gross CP; Gershman B; Leapman MS; Shah ND
    Eur Urol Focus; 2021 Jan; 7(1):86-94. PubMed ID: 31047904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized Prostate Cancer.
    Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
    Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer.
    Quinn TP; Sanda MG; Howard DH; Patil D; Filson CP
    Cancer; 2021 Aug; 127(16):2974-2979. PubMed ID: 34139027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world use of MRI for risk stratification prior to prostate biopsy.
    Siddiqui MR; Ansbro B; Shah PV; Aguiar JA; Li EV; Rich JM; Mahenthiran AK; Moataz SAS; Keeter MK; Mai Q; Mi X; Schaeffer EM; Ross AE
    Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):353-359. PubMed ID: 35551235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving Use of Prebiopsy Prostate Magnetic Resonance Imaging in the Medicare Population.
    Rosenkrantz AB; Hemingway J; Hughes DR; Duszak R; Allen B; Weinreb JC
    J Urol; 2018 Jul; 200(1):89-94. PubMed ID: 29410202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance.
    Shoag JE; Cai PY; Gross MD; Gaffney C; Li D; Mao J; Nowels M; Scherr DS; Sedrakyan A; Hu JC
    Cancer; 2020 Jul; 126(13):2986-2990. PubMed ID: 32320063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate magnetic resonance imaging utilization and its relationship with advanced prostate cancer detection.
    Qian Z; Chen YJ; Feldman J; Beatrici E; Filipas DK; Moore CM; Trinh QD; Kibel AS; Lipsitz SR; Cole AP
    Urol Oncol; 2024 Nov; 42(11):370.e1-370.e7. PubMed ID: 39013714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
    Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
    Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic Variability, Time Trends and Association of Preoperative Magnetic Resonance Imaging with Surgical Outcomes for Elderly United States Men with Prostate Cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Cole AP; Chen X; Langbein BJ; Giganti F; Kasivisvanathan V; Emberton M; Moore CM; Lipsitz SR; Keating NL; Trinh QD
    J Urol; 2022 Sep; 208(3):609-617. PubMed ID: 35536695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Winther MD; Jakobsen H; Thomsen HS
    JAMA Netw Open; 2018 Jun; 1(2):e180219. PubMed ID: 30646066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patterns.
    Liu W; Patil D; Howard DH; Moore RH; Wang H; Sanda MG; Filson CP
    Urol Oncol; 2019 Mar; 37(3):181.e15-181.e21. PubMed ID: 30514604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
    van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
    Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
    Wang K; Sheets NC; Basak R; Chen RC
    Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis.
    Drost FH; Osses D; Nieboer D; Bangma CH; Steyerberg EW; Roobol MJ; Schoots IG
    Eur Urol; 2020 Jan; 77(1):78-94. PubMed ID: 31326219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.